BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34397199)

  • 1. Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report.
    Rosso JD; Armstrong AW; Berman B; Bhatia N; Cockerell C; Goldenberg G; Kirby J; Lebwohl M; Stein Gold L; Marson JW; Rigel DS
    J Drugs Dermatol; 2021 Aug; 20(8):888-893. PubMed ID: 34397199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core Outcome Set for Actinic Keratosis Clinical Trials.
    Reynolds KA; Schlessinger DI; Vasic J; Iyengar S; Qaseem Y; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood C; Kim JYS; Lee EH; Lissner GS; Marghoob AA; Matin RN; Mattox A; Mittal BB; Thomas JR; Zhou XA; Zloty D; Schmitt J; Kirkham J; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
    JAMA Dermatol; 2020 Mar; 156(3):326-333. PubMed ID: 31939999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians.
    Richard MA; Amici JM; Basset-Seguin N; Claudel JP; Cribier B; Dreno B
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):339-346. PubMed ID: 29235161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project.
    Morton C; Baharlou S; Basset-Seguin N; Calzavara-Pinton P; Dirschka T; Gilaberte Y; Haedersdal M; Hofbauer G; Sapra S; Waalboer-Spuij R; Yip L; Szeimies RM
    Acta Derm Venereol; 2023 Jun; 103():adv6229. PubMed ID: 37289027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis.
    Berman B; Ablon GR; Bhatia ND; Ceilley RI; Goldberg DJ; Nestor MS; Weinkle SH
    J Drugs Dermatol; 2017 Mar; 16(3):260-264. PubMed ID: 28301622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current perspective on actinic keratosis: a review.
    Siegel JA; Korgavkar K; Weinstock MA
    Br J Dermatol; 2017 Aug; 177(2):350-358. PubMed ID: 27500794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results.
    Kempers S; DuBois J; Forman S; Poon A; Cutler E; Wang H; Cutler D; Fang J; Kwan R
    J Drugs Dermatol; 2020 Nov; 19(11):1093-1100. PubMed ID: 33196758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment considerations in actinic keratosis.
    Goldenberg G
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():12-16. PubMed ID: 28263018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatopathologic features of cutaneous squamous cell carcinoma and actinic keratosis: Consensus criteria and proposed reporting guidelines.
    Christensen RE; Elston DM; Worley B; Dirr MA; Anvery N; Kang BY; Bahrami S; Brodell RT; Cerroni L; Elston C; Ferringer T; Hurley MY; Garton K; Lee JSS; Liu Y; Maize JC; McNiff JM; Rapini RP; Sangueza OP; Shea CR; Zhou C; Alam M
    J Am Acad Dermatol; 2023 Jun; 88(6):1317-1325. PubMed ID: 36841336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian expert consensus paper on the management of patients with actinic keratoses.
    Moscarella E; Di Brizzi EV; Casari A; De Giorgi V; Di Meo N; Fargnoli MC; Lacarrubba F; Micali G; Pellacani G; Peris K; Piaserico S; Calzavara-Pinton P; Quaglino P; Sollena P; Zalaudek I; Zane C; Argenziano G
    Dermatol Ther; 2020 Nov; 33(6):e13992. PubMed ID: 32648324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Actinic Keratosis].
    Dejaco D; Hauser U; Zelger B; Riechelmann H
    Laryngorhinootologie; 2015 Jul; 94(7):467-79; quiz 480-1. PubMed ID: 26125293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A feasibility study of microwave therapy for precancerous actinic keratosis.
    Jackson DN; Hogarth FJ; Sutherland D; Holmes EM; Donnan PT; Proby CM
    Br J Dermatol; 2020 Aug; 183(2):222-230. PubMed ID: 32030723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a diagnostic algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma by means of high-definition optical coherence tomography.
    Marneffe A; Suppa M; Miyamoto M; Del Marmol V; Boone M
    Exp Dermatol; 2016 Sep; 25(9):684-7. PubMed ID: 27095632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folliculotropism in Actinic Keratoses in Patients not Responding to Treatments: A Pilot Study.
    Dika E; Dika E; Lambertini M; Dika E; Lambertini M; Veronesi G; Misciali C; Milani M; Bergant-Suhodolcan A; Hrvatin Stancic B; Baraldi C
    Acta Dermatovenerol Croat; 2023 Nov; 31(2):98-100. PubMed ID: 38006370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of actinic keratoses.
    Shoimer I; Rosen N; Muhn C
    Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians.
    Dréno B; Amici JM; Basset-Seguin N; Cribier B; Claudel JP; Richard MA;
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1141-9. PubMed ID: 24612407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.
    Massey PR; Schmults CD; Li SJ; Arron ST; Asgari MM; Bouwes Bavinck JN; Billingsley E; Blalock TW; Blasdale K; Carroll BT; Carucci JA; Chong AH; Christensen SR; Chung CL; DeSimone JA; Ducroux E; Escutia-Muñoz B; Ferrándiz-Pulido C; Fox MC; Genders RE; Geusau A; Gjersvik P; Hanlon AM; Olasz Harken EB; Hofbauer GFL; Hopkins RS; Leitenberger JJ; Loss MJ; Del Marmol V; Mascaró JM; Myers SA; Nguyen BT; Oliveira WRP; Otley CC; Proby CM; Rácz E; Ruiz-Salas V; Samie FH; Seçkin D; Shah SN; Shin TM; Shumack SP; Soon SL; Stasko T; Zavattaro E; Zeitouni NC; Zwald FO; Harwood CA; Jambusaria-Pahlajani A
    JAMA Dermatol; 2021 Oct; 157(10):1219-1226. PubMed ID: 34468690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
    Feldman SR; Fleischer AB
    Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Peels as Field Therapy for Actinic Keratoses: A Systematic Review.
    Jiang AJ; Soon SL; Rullan P; Brody HJ; Monheit GD; Lee KC
    Dermatol Surg; 2021 Oct; 47(10):1343-1346. PubMed ID: 34238790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "Personalising Actinic Keratosis Treatment for Immunocompromised Patients" (IM-PAKT) Project: An Expert Panel Opinion.
    Szeimies RM; Ulrich C; Ferrándiz-Pulido C; Hofbauer GFL; Lear JT; Lebbé C; Piaserico S; Hædersdal M
    Dermatol Ther (Heidelb); 2024 Jun; ():. PubMed ID: 38902589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.